Abstract:Objective To investigate the association of serum magnesium (Mg) level with all-cause mortality in maintenance hemodialysis patients. Methods A multicenter retrospective cohort study was conducted in seven hemodialysis centers of Guizhou province. The adult outpatients who underwent hemodialysis for more than 3 months were included from June 2015 to June 2016. Demographics, baseline clinical and laboratory test results were collected. All patients were followed up until June 30, 2018. Patients were divided into 4 groups according to their baseline serum Mg levels (interquartile range). Kaplan-Meier method was used to compare the survival rates of the four group. Cox regression model was used to analyze the association of Mg with all-cause mortality. Logistic regression was used to analyze the influencing factors of low Mg level. Results A total of 868 hemodialysis dialysis patients with baseline Mg data were enrolled in this study, with age of (55.47± 16.17) years old, among whom 59.4% were male. There were 11 (1.3%) patients with hypomagnesemia (Mg＜0.7 mmol/L), 432(49.8% ) patients with hypermagnesemia (Mg＞1.05 mmol/L), and 16(1.8% ) patients with Mg＞2.0 mmol/L. Median Mg was 1.05 mmol/L and interquartile range was 0.95-1.24 mmol/L. The comparison between Mg quartile groups showed that the difference in age, hemoglobin, serum albumin, serum calcium, parathyroid hormone (PTH), serum creatinine, uric acid and urea nitrogen was statistically significant (all P＜0.05). After a median follow-up of 24 months, 207 patients died. Kaplan-Meier curves showed higher all-cause mortality in patients with Mg≤0.95 mmol/L (Q1 group) (Log - rank test χ2=15.11, P=0.002). However, after adjusting for age, comorbidities and biochemical indicators(especially albumin), there was no statistically significant difference in the hazard ratio for all-cause death among the four groups. Multiple logistic regression analysis results showed that low serum albumin (OR=0.946, 95%CI 0.913-0.979, P=0.002) and low serum uric acid (OR=0.994, 95% CI 0.992-0.997, P＜0.001) were the risk factors for baseline Mg≤0.95 mmol/L. Conclusions Hypomagnesemia is rare in MHD patients, while hypermagnesemia is more common. Baseline serum Mg≤0.95 mmol/L in MHD patients is correlated with increased risk of all-cause death, but it may be not an independent risk factor. Baseline serum Mg≤0.95 mmol/L that occurred is associated with low levels of albumin and serum uric acid.

Influencing factors of serum magnesium in CKD5 patients: A multicenter study in southern China

Correlation of serum magnesium with cardiovascular risk factors in maintenance hemodialysis patients--a cross-sectional study.

Serum Magnesium Abnormality and Influencing Factors of Serum Magnesium Level in Peritoneal Dialysis Patients: A Single-Center Study in Northern China

The association of serum magnesium and chronic kidney disease: a two-sample mendelian randomization study of European descent

The association between serum magnesium and chronic kidney disease in Chinese adults: a cross-sectional study

Effects of serum magnesium level on mortality in maintenance hemodialysis patients

Mineral and Bone Disorder in Chinese Dialysis Patients: a Multicenter Study

Prognostic Value of Serum Magnesium in Mortality Risk among Patients on Hemodialysis: A Meta-Analysis of Observational Studies

Serum magnesium and cardiovascular mortality in peritoneal dialysis patients: a 5-year prospective cohort study.

Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium

Association of Serum Magnesium Level with All-Cause Mortality in Maintenance Hemodialysis Patients

Association Between Predialysis Hypermagnesaemia and Morbidity of Uraemic Restless Legs Syndrome in Maintenance Haemodialysis Patients: a Retrospective Observational Study in Zhejiang, China

Ionized and total magnesium levels in patients with chronic kidney disease: associated factors and outcomes

A multi-center study on the association between serum magnesium levels and allostatic load in hemodialysis patients

The effect of hemodialysis on serum magnesium concentration in hemodialysis patients.

Impact of different magnesium concentrations in dialysate on serum magnesium normaliza-tion and blood pressure in hemodialysis patients

Cardiovascular and All-Cause Mortality Is Affected by Serum Magnesium and Diet Pattern in a Cohort of Dialysis Patients

Serum magnesium, mortality and disease progression in chronic kidney disease

Unraveling the Mechanisms of Magnesium Supplementation in Alleviating Chronic Kidney Disease Complications and Progression: Balancing Risks and Benefits

Role Of Magnesium In The Risk Of Intradialytic Hypotension Among Maintenance Hemodialysis Patients

Urinary magnesium predicts risk of cardiovascular disease in Chronic Kidney Disease stage 1–4 patients